Editors’ Picks, March 2026: Pediatric Leukemia Development, Low-dose Tamoxifen Use, and More
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
Editor’s note: As we honor National Cancer Survivor Month, we are also recognizing the AACR Scientist↔Survivor Program’s positive impact...
Another month brings another round of Editors’ Picks! As we picked our May flowers, the editors picked their favorite...
“It is more important to know what sort of person has a disease than to know what sort of...
The American Association for Cancer Research (AACR) was thrilled to welcome Super Bowl Champion Rodney McLeod Jr. and Erika...
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
The era of targeted cancer therapy has fundamentally transformed the way several cancers are treated and has provided new...